U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 357

1.
Role of Cys‐603 in dimer/oligomer formation of the breast cancer resistance protein BCRP/ABCG2
Kumie Kage, Toshiro Fujita, Yoshikazu Sugimoto
Cancer Sci. 2005 Dec; 96(12): 866–872. Published online 2005 Dec 9. doi: 10.1111/j.1349-7006.2005.00126.x
PMCID:
PMC11159771
AbstractArticlePDF–367K
2.
ABCG2 Q141K polymorphism is associated with chemotherapy‐induced diarrhea in patients with diffuse large B‐cell lymphoma who received frontline rituximab plus cyclophosphamide/doxorubicin/ vincristine/prednisone chemotherapy
In‐Suk Kim, Hoon‐Gu Kim, Dong Chul Kim, Hyeon‐Seok Eom, Sun‐Young Kong, Ho‐Jin Shin, Sang‐Hyun Hwang, Eun‐Yup Lee, Gyeong‐Won Lee
Cancer Sci. 2008 Dec; 99(12): 2496–2501. Published online 2008 Nov 20. doi: 10.1111/j.1349-7006.2008.00985.x
PMCID:
PMC11159449
AbstractArticlePDF–141K
3.
Re‐evaluation and functional classification of non‐synonymous single nucleotide polymorphisms of the human ATP‐binding cassette transporter ABCG2
Ai Tamura, Kanako Wakabayashi, Yuko Onishi, Misako Takeda, Yoji Ikegami, Seigo Sawada, Masahisa Tsuji, Yoichi Matsuda, Toshihisa Ishikawa
Cancer Sci. 2007 Feb; 98(2): 231–239. Published online 2006 Dec 15. doi: 10.1111/j.1349-7006.2006.00371.x
PMCID:
PMC11158858
AbstractArticlePDF–815K
4.
Breast cancer resistance protein: Molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics
Yoshikazu Sugimoto, Satomi Tsukahara, Etsuko Ishikawa, Junko Mitsuhashi
Cancer Sci. 2005 Aug; 96(8): 457–465. Published online 2005 Aug 12. doi: 10.1111/j.1349-7006.2005.00081.x
PMCID:
PMC11158713
AbstractArticlePDF–236K
5.
Breast cancer resistance protein/ABCG2 is differentially regulated downstream of extracellular signal‐regulated kinase
Yasuo Imai, Kyoko Ohmori, Shin’ichi Yasuda, Mariko Wada, Tsukasa Suzuki, Kazunori Fukuda, Yoshihiko Ueda
Cancer Sci. 2009 Jun; 100(6): 1118–1127. Published online 2009 Mar 12. doi: 10.1111/j.1349-7006.2009.01154.x
PMCID:
PMC11158436
AbstractArticlePDF–3.9M
6.
Purification of breast cancer resistance protein ABCG2 and role of arginine-482
A. Pozza, J. M. Perez-Victoria, A. Sardo, A. Ahmed-Belkacem, A. Di Pietro
Cell Mol Life Sci. 2006 Aug; 63(16): 1912–1922. Published online 2006 Jul 17. doi: 10.1007/s00018-006-6159-7
PMCID:
PMC11136364
AbstractArticlePDF–311K
7.
ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer Cells
Chung-Pu Wu, Cheng-Yu Hung, Megumi Murakami, Yu-Shan Wu, Yi-Hsuan Chu, Yang-Hui Huang, Jau-Song Yu, Suresh V. Ambudkar
Int J Mol Sci. 2024 May; 25(10): 5160. Published online 2024 May 9. doi: 10.3390/ijms25105160
PMCID:
PMC11121381
AbstractArticlePDF–3.0M
8.
ABCG2 Expression as a Potential Survival Predictor in Human Gliomas
Marina Raguž, Marko Tarle, Danko Müller, Čedna Tomasović-Lončarić, Hana Chudy, Tonko Marinović, Darko Chudy
Int J Mol Sci. 2024 Mar; 25(6): 3116. Published online 2024 Mar 8. doi: 10.3390/ijms25063116
PMCID:
PMC10969902
AbstractArticlePDF–2.9M
9.
ABCG2 polymorphisms and susceptibility to ARV‐associated hepatotoxicity
HariOm Singh, Kishore Dhotre, Shyamveer, Ranjana Choudhari, Amita Verma, Supriya D. Mahajan, Nemat Ali
Mol Genet Genomic Med. 2024 Mar; 12(3): e2362. Published online 2024 Mar 7. doi: 10.1002/mgg3.2362
PMCID:
PMC10955225
AbstractArticlePDF–729K
10.
ABCG2 transporter reduces protein aggregation in cigarette smoke condensate-exposed A549 lung cancer cells
Emmanuella O. Ajenu, Ashley M. Seideneck, Esh Pandellapalli, Emily M. Shinsky, Casey L. Humphries, Nicholas L. Aparicio, Mahak Sharma, James H. Marden, Maria M. Krasilnikova
PLoS One. 2024; 19(3): e0297661. Published online 2024 Mar 5. doi: 10.1371/journal.pone.0297661
PMCID:
PMC10914296
AbstractArticlePDF–2.5M
11.
Association of ABCG2 Polymorphisms on Triple Negative Breast Cancer (TNBC) Susceptibility Risk
Yeoh Hao Ing, Md Salzihan Md Salleh, Maya Mazuwin Yahya, Ravindran Ankathil, Ahmad Aizat Abdul Aziz
Asian Pac J Cancer Prev. 2023; 24(11): 3891–3897. doi: 10.31557/APJCP.2023.24.11.3891
PMCID:
PMC10772757
AbstractArticlePDF–434K
12.
ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban
Hamin Kim, Tae-Jin Song, Jeong Yee, Dong-Hyeok Kim, Junbeom Park, Hye Sun Gwak
Drug Des Devel Ther. 2023; 17: 2513–2522. Published online 2023 Aug 23. doi: 10.2147/DDDT.S417096
PMCID:
PMC10460569
AbstractArticlePDF–1.4M
13.
The net electrostatic potential and hydration of ABCG2 affect substrate transport
Tomoka Gose, Heather M. Aitken, Yao Wang, John Lynch, Evadnie Rampersaud, Yu Fukuda, Medb Wills, Stefanie A. Baril, Robert C. Ford, Anang Shelat, Megan L. O’Mara, John D. Schuetz
Nat Commun. 2023; 14: 5035. Published online 2023 Aug 18. doi: 10.1038/s41467-023-40610-5
Correction in:
Nat Commun. 2024; 15: 8956.
PMCID:
PMC10439158
AbstractArticlePDF–3.4M
14.
Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia
Márton Pálinkás, Edit Szabó, Anna Kulin, Orsolya Mózner, Rita Rásonyi, Péter Juhász, Krisztina Nagy, György Várady, Dóra Vörös, Boglárka Zámbó, Balázs Sarkadi, Gyula Poór
Clin Exp Med. 2023; 23(4): 1277–1284. Published online 2022 Aug 8. doi: 10.1007/s10238-022-00848-7
PMCID:
PMC10390358
AbstractArticlePDF–690K
15.
Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines
Matthew Mansi, Richard Howley, Sharayu Chandratre, Bin Chen
Biochem Pharmacol. Author manuscript; available in PMC 2023 Jun 12.
Published in final edited form as: Biochem Pharmacol. 2022 Jun; 200: 115031. Published online 2022 Apr 4. doi: 10.1016/j.bcp.2022.115031
PMCID:
PMC10258830
AbstractArticlePDF–919K
16.
ABCG2 in Acute Myeloid Leukemia: Old and New Perspectives
Daniela Damiani, Mario Tiribelli
Int J Mol Sci. 2023 Apr; 24(8): 7147. Published online 2023 Apr 12. doi: 10.3390/ijms24087147
PMCID:
PMC10138346
AbstractArticlePDF–1.0M
17.
The frequency of rs2231142 in ABCG2 among Native Hawaiian and Pacific Islander subgroups: implications for personalized rosuvastatin dosing
Ola AlAzzeh, Youssef M Roman
Pharmacogenomics. 2023 Feb; 24(3): 173–182. Published online 2023 Jan 20. doi: 10.2217/pgs-2022-0160
PMCID:
PMC10072122
AbstractArticlePDF–388K
18.
The ABCG2 rs2231142 polymorphism and the risk of nephrolithiasis: A case–control study from the Taiwan biobank
Ching-Tsai Lin, I-Chieh Chen, Yen-Ju Chen, Ying-Cheng Lin, Jui-Chun Chang, Tsai-Jung Wang, Wen-Nan Huang, Yi-Hsing Chen, Yi-Huei Chen, Ching-Heng Lin, Yi-Ming Chen
Front Endocrinol (Lausanne) 2023; 14: 1074012. Published online 2023 Mar 10. doi: 10.3389/fendo.2023.1074012
PMCID:
PMC10036833
AbstractArticlePDF–580K
19.
Personalized Dose of Adjuvant Imatinib in Patients with Gastrointestinal Stromal Tumors: Results from a Population Pharmacokinetic Analysis
Xuehui Jiang, Qun Fu, Yan Jing, Ying Kong, Hong Liu, Hongwei Peng, Kaisaner Rexiti, Xiaohua Wei
Drug Des Devel Ther. 2023; 17: 809–820. Published online 2023 Mar 14. doi: 10.2147/DDDT.S400986
PMCID:
PMC10024496
AbstractArticlePDF–3.3M
20.
The frequency of rs2231142 in ABCG2 among Asian subgroups: implications for personalized rosuvastatin dosing
Khalifa Alrajeh, Youssef M. Roman
Pharmacogenomics. 2023 Jan; 24(1): 15–26. Published online 2023 Jan 18. doi: 10.2217/pgs-2022-0155
PMCID:
PMC9979151
AbstractArticlePDF–801K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center